The world needs BIOMATDB

As the European Green Deal is becoming a reality, so does the need for information about the carbon footprint and the sustainability of biomaterials.

Biomaterials have become a critical component in healthcare and medicine, offering new and innovative ways to improve patient outcomes and overall quality of care. These materials have unique properties that make them ideal for use in a variety of medical applications, including implantable devices, drug delivery systems, and tissue engineering. However, as the use of biomaterials continues to grow, so does the need for information about their properties, applicability, carbon and digital footprint, and their overall sustainability.

For context, biomaterials are synthetic or natural materials that are used in medical applications. They are designed to interact with biological systems and can be used to replace or repair damaged tissue, support tissue regeneration, and deliver drugs. Biomaterials can be derived from a variety of sources, including metals, ceramics, polymers, and natural materials such as collagen and silk.

And while biomaterials offer numerous benefits, there are also sustainability questions that should be addressed. I was not necessarily aware of them until I conducted the interviews with the hospital managers responsible for tendering biomaterials for their organisations. One of those interviews happened within the framework of the BIOMATDB project. The other one was conducted during the Green Health session at the Digital Health & Wellness Summit in Barcelona in February 2023 that I moderated. Both managers agreed that, as the world and requirements and expectations for the procurement procedures change, they need more detailed information on the source of the biomaterials, how to dispose of them, if they can be reused or repurposed and how, and what’s their carbon footprint. This is particularly important as many biomaterials are derived from non-renewable resources and require significant energy and resources to produce. Additionally, the disposal of biomaterials at the end of their life can have significant environmental impacts.

The need for this specific information is in line with the framework of green health or zero net healthcare. As a concept, zero net healthcare aims to reduce the environmental impact of healthcare facilities and operations to net zero, meaning that the environmental impact is offset by an equal or greater amount of environmental benefit. It is part of the thinking behind the European Green Deal and an important effort in achieving carbon neutrality by 2050.

That is why the world needs BIOMATDB – Advanced Database and Marketplace for Biomaterials – to deliver a database with information that matters for healthcare professionals, managers, suppliers and purchasers, so they have the ability to compare an even larger number of biomaterials, giving them the chance to choose the best product for their particular needs and requirements.

You can now make the BIOMATDB solution better by helping identify gaps and needs within the biomaterials niche, or bringing forward novel products to meet the market demand. Participate in the survey on the BIOMATDB website:

Author: Karolina Mackiewicz


green health, digital health, sustainability, net zero healthcare, green deal